Jill Chrencik

2.0k total citations
18 papers, 1.1k citations indexed

About

Jill Chrencik is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jill Chrencik has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Jill Chrencik's work include Cytokine Signaling Pathways and Interactions (5 papers), Cancer therapeutics and mechanisms (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Jill Chrencik is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Cancer therapeutics and mechanisms (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Jill Chrencik collaborates with scholars based in United States, Switzerland and Austria. Jill Chrencik's co-authors include Matthew R. Redinbo, Yves Pommier, Lance Stewart, Alex B. Burgin, Alexei Brooun, Hans Widmer, Peter Kühn, Michael I. Recht, Steven A. Kliewer and Yu Xue and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Jill Chrencik

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Jill Chrencik

Since Specialization

Citations

This map shows the geographic impact of Jill Chrencik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Chrencik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Chrencik more than expected).

Fields of papers citing papers by Jill Chrencik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Chrencik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Chrencik. The network helps show where Jill Chrencik may publish in the future.

Co-authorship network of co-authors of Jill Chrencik

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Chrencik. A scholar is included among the top collaborators of Jill Chrencik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Chrencik. Jill Chrencik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits 2017 ·Journal of Medicinal Chemistry ·Mark E. Schnute, Matthew D. McReynolds, (unknown), Jill Chrencik, Maureen Highkin, (unknown), Gina Jerome, (unknown), Matthew J. Saabye, Jeffrey A. Scholten, Matthew Yates, M. Marek Nagiec	38
2	Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin 2016 ·Journal of Medicinal Chemistry ·Peter Jones, Richard Storer, Yogesh Sabnis, Florian Wakenhut, Gavin A. Whitlock, Katherine S. England, T. MUKAIYAMA, Christoph M. Dehnhardt, Jotham W. Coe, (unknown), Jill Chrencik, David G. Brown, Rhys Jones, John R. Murphy, (unknown), Paul Morgan, Iain Kilty	44
3	Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1 2015 ·Cell ·Jill Chrencik, C. Roth, (unknown), H. Kurata, R. Omi, Yasuyuki Kihara, Dora Toledo Warshaviak, Shinji Nakade, (unknown), Mauro Mileni, Hirotaka Mizuno, Mark T. Griffith, Caroline Rodgers, Gye Won Han, Jeffrey Velasquez, Jerold Chun, Raymond C. Stevens, Michael A. Hanson	147
4	Structure of human ADAM-8 catalytic domain complexed with batimastat 2012 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Troii Hall, Huey‐Sheng Shieh, Jacqueline E. Day, Nicole Caspers, Jill Chrencik, Jennifer M. Williams, Lyle E. Pegg, Adele M. Pauley, A.F. Moon, Joseph M. Krahn, David Fischer, James R. Kiefer, Alfredo G. Tomasselli, Marc D. Zack	13
5	Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6 2010 ·Journal of Molecular Biology ·Jill Chrencik, Akshay Patny, Iris Leung, (unknown), Thomas L. Emmons, Troii Hall, Robin A. Weinberg, (unknown), Jennifer M. Williams, Jacqueline E. Day, Jeffrey L. Hirsch, James R. Kiefer, Joseph W. Leone, Heinz Fischer, Cynthia D. Sommers, H. T. Huang, E. Jon Jacobsen, Ruth E. TenBrink, Alfredo G. Tomasselli, Timothy E. Benson	173
6	Expression, purification, and characterization of TYK-2 kinase domain, a member of the Janus kinase family 2010 ·Biochemical and Biophysical Research Communications ·(unknown), Arthur J. Wittwer, Thomas L. Emmons, Troii Hall, (unknown), (unknown), Jeffrey L. Hirsch, (unknown), Robin A. Weinberg, Joseph W. Leone, Jacqueline E. Day, Jill Chrencik, Cynthia D. Sommers, Heinz Fischer, Alfredo G. Tomasselli	4
7	Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides 2010 ·Journal of Biological Chemistry ·(unknown), Julia A. Guzova, Sumathy Mathialagan, (unknown), Medora M. Hardy, (unknown), Sheri L. Bonar, Robin A. Weinberg, Shaun R. Selness, Scott S. Woodard, Jill Chrencik, William F. Hood, John F. Schindler, Nandini Kishore, Gabriel Mbalaviele	38
8	Expression, purification, characterization and crystallization of non- and phosphorylated states of JAK2 and JAK3 kinase domain 2009 ·Protein Expression and Purification ·Troii Hall, Thomas L. Emmons, Jill Chrencik, (unknown), Robin A. Weinberg, Joseph W. Leone, Jeffrey L. Hirsch, Matthew J. Saabye, John F. Schindler, Jacqueline E. Day, Jennifer M. Williams, James R. Kiefer, Sandra Lightle, Melissa S. Harris, Siradanahalli C. Guru, Heinz Fischer, Alfredo G. Tomasselli	18
9	Structural Basis of Guanine Nucleotide Exchange Mediated by the T-Cell Essential Vav1 2008 ·Journal of Molecular Biology ·Jill Chrencik, Alexei Brooun, Hui Zhang, Irimpan I. Mathews, Greg L. Hura, Scott A. Foster, J. Jefferson P. Perry, Markus Streiff, Paul Ramage, Hans Widmer, Gary Bokoch, John A. Tainer, Gisbert Weckbecker, Peter Kühn	49
10	Three-dimensional Structure of the EphB2 Receptor in Complex with an Antagonistic Peptide Reveals a Novel Mode of Inhibition 2007 ·Journal of Biological Chemistry ·Jill Chrencik, Alexei Brooun, Michael I. Recht, George Nicola, (unknown), Ruben Abagyan, Hans Widmer, Elena B. Pasquale, Peter Kühn	49
11	Structure and Thermodynamic Characterization of the EphB4/Ephrin-B2 Antagonist Peptide Complex Reveals the Determinants for Receptor Specificity 2006 ·Structure ·Jill Chrencik, Alexei Brooun, Michael I. Recht, Michelle L. Kraus, Mitchell Koolpe, Anand Kolatkar, Richard H. Bruce, Georg Martiny‐Baron, Hans Widmer, Elena B. Pasquale, Peter Kühn	75
12	Remedial strategies in structural proteomics: Expression, purification, and crystallization of the Vav1/Rac1 complex 2006 ·Protein Expression and Purification ·Alexei Brooun, Scott A. Foster, Jill Chrencik, Ellen Y. T. Chien, Anand Kolatkar, Markus Streiff, Paul Ramage, Hans Widmer, Gisbert Weckbecker, Peter Kühn	7
13	Structural and Biophysical Characterization of the EphB4·EphrinB2 Protein-Protein Interaction and Receptor Specificity 2006 ·Journal of Biological Chemistry ·Jill Chrencik, Alexei Brooun, Michelle L. Kraus, Michael I. Recht, Anand Kolatkar, Gye Won Han, Jan Seifert, Hans Widmer, Manfred Auer, Peter Kühn	79
14	Structural Disorder in the Complex of Human Pregnane X Receptor and the Macrolide Antibiotic Rifampicin 2005 ·Molecular Endocrinology ·Jill Chrencik, Jillian Orans, Linda B. Moore, Yu Xue, Li Peng, Jon L. Collins, G. Bruce Wisely, Millard H. Lambert, Steven A. Kliewer, Matthew R. Redinbo	160
15	Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations 2004 ·Journal of Molecular Biology ·Jill Chrencik, Bart L. Staker, Alex B. Burgin, Philippe Pourquier, Yves Pommier, Lance Stewart, Matthew R. Redinbo	113
16	Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations 2004 ·Journal of Molecular Biology ·Jill Chrencik	3
17	STRUCTURAL IMPACT OF THE LEUKEMIA DRUG 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) ON THE COVALENT HUMAN TOPOISOMERASE I-DNA COMPLEX 2003 ·Thermochimica Acta ·Jill Chrencik, Alex B. Burgin, Yves Pommier, Lance Stewart, Matthew R. Redinbo	1
18	Structural Impact of the Leukemia Drug 1--d-Arabinofuranosylcytosine (Ara-C) on the Covalent Human Topoisomerase I-DNA Complex 2003 ·Journal of Biological Chemistry ·Jill Chrencik, Alex B. Burgin, Yves Pommier, Lance Stewart, Matthew R. Redinbo	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact